1-111982352-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001378969.1(KCND3):​c.375G>A​(p.Pro125Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00964 in 1,614,078 control chromosomes in the GnomAD database, including 581 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P125P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.023 ( 97 hom., cov: 32)
Exomes 𝑓: 0.0082 ( 484 hom. )

Consequence

KCND3
NM_001378969.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.67

Publications

5 publications found
Variant links:
Genes affected
KCND3 (HGNC:6239): (potassium voltage-gated channel subfamily D member 3) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shal-related subfamily, members of which form voltage-activated A-type potassium ion channels and are prominent in the repolarization phase of the action potential. This member includes two isoforms with different sizes, which are encoded by alternatively spliced transcript variants of this gene. [provided by RefSeq, Jul 2008]
KCND3 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • spinocerebellar ataxia type 19/22
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • Brugada syndrome 9
    Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 1-111982352-C-T is Benign according to our data. Variant chr1-111982352-C-T is described in ClinVar as Benign. ClinVar VariationId is 380951.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.67 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0891 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001378969.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCND3
NM_001378969.1
MANE Select
c.375G>Ap.Pro125Pro
synonymous
Exon 2 of 8NP_001365898.1Q9UK17-1
KCND3
NM_004980.5
c.375G>Ap.Pro125Pro
synonymous
Exon 2 of 8NP_004971.2
KCND3
NM_001378970.1
c.375G>Ap.Pro125Pro
synonymous
Exon 2 of 7NP_001365899.1Q9UK17-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCND3
ENST00000302127.5
TSL:5 MANE Select
c.375G>Ap.Pro125Pro
synonymous
Exon 2 of 8ENSP00000306923.4Q9UK17-1
KCND3
ENST00000315987.6
TSL:1
c.375G>Ap.Pro125Pro
synonymous
Exon 2 of 8ENSP00000319591.2Q9UK17-1
KCND3
ENST00000369697.5
TSL:1
c.375G>Ap.Pro125Pro
synonymous
Exon 1 of 6ENSP00000358711.1Q9UK17-2

Frequencies

GnomAD3 genomes
AF:
0.0231
AC:
3511
AN:
152080
Hom.:
97
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0607
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0157
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.0960
Gnomad SAS
AF:
0.0210
Gnomad FIN
AF:
0.00217
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.00118
Gnomad OTH
AF:
0.0234
GnomAD2 exomes
AF:
0.0186
AC:
4681
AN:
251386
AF XY:
0.0163
show subpopulations
Gnomad AFR exome
AF:
0.0616
Gnomad AMR exome
AF:
0.0277
Gnomad ASJ exome
AF:
0.000595
Gnomad EAS exome
AF:
0.100
Gnomad FIN exome
AF:
0.00277
Gnomad NFE exome
AF:
0.000985
Gnomad OTH exome
AF:
0.0111
GnomAD4 exome
AF:
0.00824
AC:
12044
AN:
1461880
Hom.:
484
Cov.:
32
AF XY:
0.00831
AC XY:
6045
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.0645
AC:
2159
AN:
33480
American (AMR)
AF:
0.0251
AC:
1123
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000574
AC:
15
AN:
26136
East Asian (EAS)
AF:
0.129
AC:
5130
AN:
39700
South Asian (SAS)
AF:
0.0193
AC:
1661
AN:
86258
European-Finnish (FIN)
AF:
0.00285
AC:
152
AN:
53406
Middle Eastern (MID)
AF:
0.0114
AC:
66
AN:
5768
European-Non Finnish (NFE)
AF:
0.000847
AC:
942
AN:
1112012
Other (OTH)
AF:
0.0132
AC:
796
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
844
1688
2531
3375
4219
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0231
AC:
3521
AN:
152198
Hom.:
97
Cov.:
32
AF XY:
0.0232
AC XY:
1726
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.0607
AC:
2521
AN:
41520
American (AMR)
AF:
0.0160
AC:
244
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3470
East Asian (EAS)
AF:
0.0961
AC:
495
AN:
5152
South Asian (SAS)
AF:
0.0206
AC:
99
AN:
4810
European-Finnish (FIN)
AF:
0.00217
AC:
23
AN:
10616
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00118
AC:
80
AN:
68018
Other (OTH)
AF:
0.0232
AC:
49
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
157
315
472
630
787
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00930
Hom.:
54
Bravo
AF:
0.0266
Asia WGS
AF:
0.0570
AC:
199
AN:
3478
EpiCase
AF:
0.00174
EpiControl
AF:
0.00148

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
1
Cardiovascular phenotype (1)
-
-
1
not provided (1)
-
-
1
Spinocerebellar ataxia type 19/22 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
1.1
DANN
Benign
0.89
PhyloP100
-1.7
PromoterAI
0.0054
Neutral
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2289723; hg19: chr1-112524974; COSMIC: COSV56181318; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.